Foreword

Foreword

Mr. Earl Rattray Chair, India New Zealand Business Council

India New Zealand Business Council and the Indian High Commission are proud to present to you our latest publication on the Health and Pharmaceutical Landscape of New Zealand.

This report emerged out of many conversations from our event late last year, held in the midst of a growing need for collaborations between countries to put an end to a pandemic unlike any our generation had ever seen. Thankfully, we are now in a much better position in recovering from this crisis. It is a testament to the incredible resilience everyone has collectively shown in the face of a crisis like a few others.

It has been a time of profound change; but the nature and shape of that change is not yet fully apparent. As we emerge from the Covid era, the continued need for collaboration between nations to provide a sustainable and healthy future for the world is very evident.

Being the Pharmaceutical capital of the world, India led the charge in providing over 66 million doses to nearly 100 countries, while immunising its own population of over 1 billion. New Zealand is one of the greatest success stories in managing the pandemic, with a low mortality and an economy that’s slowly heading towards an early recovery. Both nations are turning a leaf over into a new era – an era where collaborations to ensure equitable access to healthcare is of paramount importance.

Into this era, India New Zealand Business Council is pleased to launch this report that provides a comprehensive outlook of the New Zealand health and pharmaceutical sector.

New Zealand’s pharmaceutical sector is unique and highly regulated one. While the buying of medicines and related products is done by the government, the management is looked after by Pharmac, a New Zealand government agency that decides which medicines are funded in New Zealand.

With this report, the council aims to shed light on these different aspects of this industry including providing a pathway to export to NZ. Our primary objective is to help increase collaboration between Indian pharmaceutical companies and distribution agencies of NZ.

We are grateful to the Indian High Commission and to the Indian High Commissioner to New Zealand, Muktesh Pardeshi for his leadership and vision in conceptualising this report. We value the trust placed in the India New Zealand Business Council to develop this report. We would also like to extend our appreciation to industry professionals and organisations who have participated and guided us in this research.

The Council trusts that the insights provided in this report guide businesses to make informed decisions about the New Zealand pharmaceutical sector.

Disclaimer: This report is a collection of primary and secondary data, available through research and interviews. INZBC and the Indian High Commission, NZ, does not take responsibility of any business decisions taken, on the basis of this report. The objective of this report is to form a broad view of the Pharma Sector in New Zealand. Companies wishing to invest in New Zealand, are encouraged to do their own research.